Stocks360

DA32 Life Science Tech Acquisition Corp. (DALS)

Stock analysis · NASDAQ · Financial Services · Shell Companies

Share: Facebook X WhatsApp SMS
$10.30

Get deeper signals and personalized alerts

Free account signup in under 60 seconds

Create free account → I already have an account
Market Cap
$264.19M
PE (TTM)
N/A
EPS (TTM)
N/A
Dividend Yield
N/A
Beta
0.00
Day Range
$10.29 – $10.32
52-wk Range
$9.68 – $11.22
Avg Volume
N/A
Volume
2.25K

DA32 Life Science Tech Acquisition Corp. (DALS) is a Stock listed on the NASDAQ exchange with a recent price of $10.30 and a market capitalization of $264,195,000. The company operates in the Financial Services sector, specifically within the Shell Companies industry. As a blank check company, DA32 Life Science Tech Acquisition Corp. aims to complete a business combination in the biotechnology and life science infrastructure sectors. To learn more about DALS, explore the data and analysis below.

DA32 Life Science Tech Acquisition Corp. (DALS) is a publicly traded company in the Financial Services sector. Latest price: $10.30. Market cap $264.19M. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

Proprietary Signals

Signal snapshot temporarily unavailable.

About DA32 Life Science Tech Acquisition Corp.

Currently, DA32 Life Science Tech Acquisition Corp. does not engage in substantial operational activities. Its core objective is to finalize a business combination, which may involve a merger, an exchange of capital stock, an acquisition of assets or stock, or a corporate reorganization with other companies. The firm intends to pinpoint promising candidates for these combinations within the biotechnology and life science infrastructure sectors. Established in 2021, the company is based in New York, New York.

Peers

Recent News

  • No recent news available.

Related

Browse more tickers: sitemap